Last reviewed · How we verify

NCT06689020: PEP-RECRUIT

Positive Expiratory Pressure (PEP) and Continuous High-frequency Oscillation (CHFO) on Lung RECRUITment Using Electrical Impedance Tomography (EIT) - The PEP-RECRUIT Study

Not yet recruiting Last updated 14 November 2024
What this trial tests

trial testing Continuous high-frequency oscillation (CHFO) and continuous positive expiratory pressure (CPEP) therapy in Recruitment in 26 participants. Not yet recruiting.

Timeline
1 December 2024
Primary endpoint
1 June 2025
1 July 2025

Quick facts

Lead sponsorUniversity of Genova
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment26
Start date1 December 2024
Primary completion1 June 2025
Estimated completion1 July 2025
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University of Genova

Who can join

18 and older, any sex, with Recruitment or Respiratory Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This single-center observational study aims to assess the effects of continuous high-frequency oscillation (CHFO) and continuous positive expiratory pressure (CPEP) therapy on lung recruitment using electrical impedance tomography (EIT) in spontaneously breathing patients admitted to the intensive care unit.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Recruitment

Currently open trials in the same condition.

Other University of Genova trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06689020.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing